Mpox is caused by a zoonotic virus belonging to the Orthopoxvirus genus and the Poxviridae family. In this study, we develop a recombinase polymerase amplification (RPA)-coupled CRISPR-Cas12a detection assay for the mpox virus. We design and test a series of CRISPR-derived RNAs(crRNAs) targeting the conserved D6R and E9L genes for orthopoxvirus and the unique N3R and N4R genes for mpox viruses. D6R crRNA-1 exhibits the most robust activity in detecting orthopoxviruses, and N4R crRNA-2 is able to distinguish the mpox virus from other orthopoxviruses. The Cas12a/crRNA assay alone presents a detection limit of 108 copies of viral DNA, whereas coupling RPA increases the detection limit to 1-10 copies. The one-tube RPA-Cas12a assay can, therefore, detect viral DNA as low as 1 copy within 30 min and holds the promise of providing point-of-care detection for mpox viral infection.
SARS-CoV-2 has become a global threat to public health. Infected individuals can be asymptomatic or develop mild to severe symptoms, including pneumonia, respiratory distress, and death. This wide spectrum of clinical presentations of SARS-CoV-2 infection is believed in part due to the polymorphisms of key genetic factors in the population. In this study, we report that the interferon-induced antiviral factor IFITM3 inhibits SARS-CoV-2 infection by preventing SARS-CoV-2 spike-protein-mediated virus entry and cell-to-cell fusion. Analysis of a Chinese COVID-19 patient cohort demonstrates that the rs12252 CC genotype of IFITM3 is associated with SARS-CoV-2 infection risk in the studied cohort. These data suggest that individuals carrying the rs12252 C allele in the IFITM3 gene may be vulnerable to SARS-CoV-2 infection and thus may benefit from early medical intervention.
Since May 2022, the multi-country outbreak of monkeypox (mpox) has raised a great concern worldwide. Early detection of mpox virus infection is recognized as an efficient way to prevent mpox transmission. Mpox specific detection methods reported up to now are based on the SNPs among mpox virus and other orthopoxviruses. We have therefore developed a real-time PCR based mpox detection method targeting mpox virus specific sequences (N3R and B18Rplus). We have also optimized an orthopoxvirus detection system which targets the highly conserved E9L and D6R genes. The mpox and orthopoxvirus real-time PCR assays have a high sensitivity (1 copy/reaction) and specificity. Mpox viral DNA and clinical samples from mpox patients are detected with the mpox detection system. Furthermore, we have established a multiplex real-time PCR detection system allowing simultaneous and efficient detection of mpox and orthopoxvirus infections.
• Significance of the study Our study emphasizes the prolonged viability of poxviruses in the environment and presents a simple yet effective approach to inactivate them using easily accessible disinfectants. This research is expected to contribute to the control of mpox virus and prevention of future poxvirus outbreaks. • Scientific question The outbreak of mpox (also known as monkeypox) in multiple regions worldwide since 2022 has elicited public concerns. Nonetheless, there is a dearth of comprehensive research of poxvirus regarding its survivability in various environments and its susceptibility to disinfectants. • Evidence before this study The mpox virus has the ability to infect various species of mammals, and it is believed that terrestrial and arboreal rodents are capable of transmitting mpox to humans. Transmission occurs primarily through direct contact with body fluids or lesions, respiratory droplets, and contaminated objects, and there have been reports of sustained human-to-human transmission during this epidemic. Vaccinia virus and other poxviruses exhibit similarities in their stability in human excretions and on commonly touched surfaces due to their high conservation. Therefore, it is imperative to understand the persistence of vaccinia virus in the environment and its susceptibility to various disinfection methods. • New findings In this study, we conducted a systematic investigation to determine the stability of the vaccinia virus, which serves as a representative of poxviruses, under various environmental conditions and assess its susceptibility to inactivation methods using plaque assay, quantitative real-time polymerase chain reaction (qPCR), and the Gaussia luciferase (G-luciferase) reporter system. Our findings provide compelling evidence that the vaccinia virus remains stable on majority of tested materials and media. Furthermore, we observed that the virus remains viable for prolonged periods at temperatures of 4 °C and −20 °C, while it can be effectively inactivated through ultraviolet (UV) irradiation, heat treatment, and chemical agents.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines provide essential tools for the control of the COVID-19 pandemic. A number of technologies have been employed to develop SARS-CoV-2 vaccines, including the inactivated SARS-CoV-2 particles, mRNA to express viral spike protein, recombinant spike proteins, and viral vectors. Here, we report the use of the vaccinia virus Tiantan strain as a vector to express the SARS-CoV-2 spike protein. When it was used to inoculate mice, robust SARS-CoV-2 spike protein-specific antibody response and T-cell response were detected. Sera from the vaccinated mice showed strong neutralizing activity against the ancestral Wuhan SARS-CoV-2, the variants of concern (VOCs) B.1.351, B.1.617.2, and the emerging B.1.1.529 (omicron). This finding supports the possibility of developing a new type of SARS-CoV-2 vaccine using the vaccinia virus vector.
4 November 2025 in Journal of Biological Chemistry
The Membrane-Associated RING-CH (MARCH) family of E3 ubiquitin ligases modulates membrane protein stability and contributes to host antiviral immune responses. Their functions largely depend on the nature of protein substrates. In this study, we identified interferon-induced transmembrane protein 3 (IFITM3), a critical antiviral effector protein, as a novel substrate of MARCH8 by co-immunoprecipitation (co-IP) coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. Mechanistically, MARCH8 promotes the lysosomal degradation of IFITM3 primarily through K63-linked polyubiquitination at lysine 24 (K24), which facilitates its trafficking and turnover from plasma membrane to endosomes and lysosomes. MARCH8 knockout cells exhibit plasma membrane accumulation of IFITM3 compared to wild-type controls after interferon (IFN) treatment. Functionally, MARCH8 expression attenuated the IFITM3-mediated restriction of vesicular stomatitis virus (VSV) and influenza A virus (IAV) entry, thereby increasing cell susceptibility to viral infection. Together, these findings establish a novel regulatory mechanism whereby MARCH8 modulates innate immunity through regulating the trafficking and turnover of antiviral protein IFITM3.